Please assess the completion status of the following clinical trial:

Trial Title: To Determine the Feasibility of a Fidaxomicin Study in Neonates and to Assess C. Difficile (Clostridium Difficile) Involvement in the Pathogenesis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subject is suffering from diarrhea or other signs or symptoms consistent with CDAD (as described in section 5.2.3)~* Presence of either toxin A or B (or both) of C. difficile in the stool within 24 hours prior to enrollment using the C. difficile Quik Chek Complete® diagnostic test, provided by the sponsor~Exclusion Criteria:~Subject will be excluded from participation if any of the following apply:~* Preterm neonates~* Negative C. difficile toxin test

- Gender: ALL
- Minimum Age: None
- Maximum Age: 27 Days
- Healthy Volunteers: f

Study Arms:
- Neonates (Type: None): Neonates with CDAD

Based on this trial design, predict the completion outcome and termination type (if applicable).